Episode
Patient Equity Capital is a Virtue
- Podcast
- RiskReversal Pod
- Published
- Jul 8, 2026
- Duration seconds
- 1613
- Processing state
not_requested- Canonical source
- https://traffic.megaphone.fm/RRM6393288042.mp3
Actions
POST https://stenobird.com/v1/public/podcasts/riskreversal-pod-1366742/episodes/patient-equity-capital-is-a-virtue/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/riskreversal-pod-1366742/patient-equity-capital-is-a-virtue.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dan Nathan and Guy Adami open the podcast by framing the day’s key market story as sharp weakness and heightened volatility in memory, chips, and semi equipment, citing rapid reversals in names like Micron and Applied Materials and opaque guidance from Samsung. They discuss whether the AI build-out is increasingly debt-funded—highlighting Amazon and Oracle debt issuance and private credit deals—and reference a “Groundbreaker” piece shared by Jim Chanos arguing investors miss second-derivative slowdowns and that AI resembles a credit-driven real estate cycle more like 2008 than 2000’s patient equity bubble. They note a rotation bounce into software (Microsoft, Palantir, Salesforce, Adobe, ServiceNow) but question sustainability, and debate SpaceX’s fast-tracked inclusion in the Nasdaq 100 after its IPO, the stock’s poor trading, possible broader IPO implications, and an upcoming insider share unlock —FOLLOW USYouTube: @RiskReversalMediaInstagram: @riskreversalmediaTwitter: @RiskReversalLinkedIn: RiskReversal Media The financial opinions expressed in Risk Reversal content are for information purposes only. The opinions expressed by the hosts and participants are not an attempt to influence specific trading behavior, investments, or strategies. Past performance does not necessarily predict future outcomes. No specific results or profits are assured when relying on Risk Reversal. Before making any investment or trade, evaluate its suitability for your circumstances and consider consulting your own financial or investment advisor. The financial products discussed in Risk Reversal carry a high level of risk and may not be appropriate for many investors. If you have uncertainties, it's advisable to seek professional advice. Remember that trading involves a risk to your capita…